Engineering synthetically modified insulin for glucose-responsive diabetes therapy

References

• Patterson CC, Dahlquist GG, Gyurus E, E.S Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373(9680):2027-33
   PubMed Web of Science ®Google Scholar
• Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414(6865):782-7
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-53
   PubMed Web of Science ®Google Scholar
• DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA 2003;289(17):2254-64
   PubMed Web of Science ®Google Scholar
• Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger PM. Insulin adherence behaviours and barriers in the multinational global attitudes of patients and physicians in insulin therapy study. Diabet Med 2012;29(5):682-9
   PubMed Web of Science ®Google Scholar
• McCoy RG, Van Houten HK, Ziegenfuss JY, et al. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care 2012;35(9):1897-901
   PubMed Web of Science ®Google Scholar
• Muggeo M, Zoppini G, Bonora E, et al. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. Diabetes Care 2000;23(1):45-50
   PubMed Web of Science ®Google Scholar
• Hirsch IB. Insulin analogues. N Engl J Med 2005;352(2):174-83
   PubMed Web of Science ®Google Scholar
• Owens DR. New horizons–alternative routes for insulin therapy. Nat Rev Drug Discov 2002;1(7):529-40
   PubMed Web of Science ®Google Scholar
• Holleman F, Hoekstra JB. Insulin lispro. N Engl J Med 1997;337(3):176-83
   PubMed Web of Science ®Google Scholar
• Rosenstock J, Schwartz SL, Clark CMJr, et al. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care 2001;24(4):631-6
   PubMed Web of Science ®Google Scholar
• Bratlie KM, York RL, Invernale MA, et al. Materials for diabetes therapeutics. Adv Healthc Mater 2012;1(3):267-84
   Web of Science ®Google Scholar
• Webber MJ, Anderson DG. Smart approaches to glucose-responsive drug delivery. J Drug Targeting 2015; In press; doi:10.3109/1061186X.2015.1055749
   Google Scholar
• Veiseh O, Tang BC, Whitehead KA, et al. Managing diabetes with nanomedicine: challenges and opportunities. Nat Rev Drug Discov 2015;14(1):45-57
   PubMed Web of Science ®Google Scholar
• Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev 2001;53(3):321-39
   PubMed Web of Science ®Google Scholar
• Mo R, Jiang T, Di J, et al. Emerging micro- and nanotechnology based synthetic approaches for insulin delivery. Chem Soc Rev 2014;43(10):3595-629
   PubMed Web of Science ®Google Scholar
• Ravaine V, Ancla C, Catargi B. Chemically controlled closed-loop insulin delivery. J Control Release 2008;132(1):2-11
   PubMed Web of Science ®Google Scholar
• Traitel T, Cohen Y, Kost J. Characterization of glucose-sensitive insulin release systems in simulated in vivo conditions. Biomaterials 2000;21(16):1679-87
   PubMed Web of Science ®Google Scholar
• Zhang K, Wu XY. Modulated insulin permeation across a glucose-sensitive polymeric composite membrane. J Control Release 2002 80(1-3):169-78
   Google Scholar
• Podual K, Doyle FJ, Peppas NA. Glucose-sensitivity of glucose oxidase-containing cationic copolymer hydrogels having poly(ethylene glycol) grafts. J Control Release 2000;67(1):9-17
   PubMed Web of Science ®Google Scholar
• Ishihara K, Kobayashi M, Ishimaru N, Shinohara I. Glucose-induced permeation control of insulin through a complex membrane consisting of immobilized glucose-oxidase and a poly(Amine). Polym J 1984;16(8):625-31
   Web of Science ®Google Scholar
• Albin G, Horbett TA, Ratner BD. Glucose sensitive membranes for controlled delivery of insulin: Insulin transport studies. J Controlled Rel 1985;2(0):153-64
   Google Scholar
• Gu Z, Aimetti AA, Wang Q, et al. Injectable nano-network for glucose-mediated insulin delivery. ACS Nano 2013;7(5):4194-201
   PubMed Web of Science ®Google Scholar
• Gu Z, Dang TT, Ma M, et al. Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery. ACS Nano 2013;7(8):6758-66
   PubMed Web of Science ®Google Scholar
• Taylor MJ, Tanna S, Taylor PM, Adams G. The delivery of insulin from aqueous and non-aqueous reservoirs governed by a glucose sensitive gel membrane. J Drug Target 1995;3(3):209-16
   PubMed Web of Science ®Google Scholar
• Nakamae K, Miyata T, Jikihara A, Hoffman AS. Formation of poly(Glucosyloxyethyl Methacrylate)-concanavalin-a complex and its glucose-sensitivity. J Biomater Sci Polym Ed 1994;6(1):79-90
   PubMed Web of Science ®Google Scholar
• Yin R, Tong Z, Yang D, Nie J. Glucose and pH dual-responsive concanavalin A based microhydrogels for insulin delivery. Int J Biol Macromol 2011;49(5):1137-42
   PubMed Web of Science ®Google Scholar
• Yin R, Tong Z, Yang D, Nie J. Glucose-responsive insulin delivery microhydrogels from methacrylated dextran/concanavalin A: preparation and in vitro release study. Carbohydr Polym 2012;89(1):117-23
   PubMed Web of Science ®Google Scholar
• Kataoka K, Miyazaki H, Okano T, Sakurai Y. Sensitive glucose-induced change of the lower critical solution temperature of poly[N,N-dimethylacrylamide-Co-3-(Acrylamido)phenyl-boronic acid] in physiological saline. Macromolecules 1994;27(4):1061-2
   Web of Science ®Google Scholar
• Kitano S, Koyama Y, Kataoka K, et al. A novel drug delivery system utilizing a glucose responsive polymer complex between poly(Vinyl Alcohol) and poly(N-Vinyl-2-Pyrrolidone) with a phenylboronic acid moiety. J Control Release 1992;19(1-3):162-70
   Google Scholar
• Shiino D, Murata Y, Kataoka K, et al. Preparation and characterization of a glucose-responsive insulin-releasing polymer device. Biomaterials 1994;15(2):121-8
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Ikeda S, Harada A, Kataoka K. Glucose-responsive polymer bearing a novel phenylborate derivative as a glucose-sensing moiety operating at physiological pH conditions. Biomacromolecules 2003;4(5):1410-16
   PubMed Web of Science ®Google Scholar
• Kataoka K, Miyazaki H, Bunya M, et al. Totally synthetic polymer gels responding to external glucose concentration: Their preparation and application to on-off regulation of insulin release. J Am Chem Soc 1998;120(48):12694-5
   Web of Science ®Google Scholar
• Weinzimer SA, Steil GM, Swan KL, et al. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31(5):934-9
   PubMed Web of Science ®Google Scholar
• El-Khatib FH, Jiang J, Damiano ER. Adaptive closed-loop control provides blood-glucose regulation using dual subcutaneous insulin and glucagon infusion in diabetic Swine. J Diabetes Sci Technol 2007;1(2):181-92
   PubMedGoogle Scholar
• Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014;371(4):313-25
   PubMed Web of Science ®Google Scholar
• El-Khatib FH, Russell SJ, Magyar KL, et al. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metab 2014;99(5):1701-11
   PubMed Web of Science ®Google Scholar
• El-Khatib FH, Russell SJ, Nathan DM, et al. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010;2(27):27ra27
   PubMed Web of Science ®Google Scholar
• Russell SJ, El-Khatib FH, Nathan DM, et al. Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care 2012;35(11):2148-55
   PubMed Web of Science ®Google Scholar
• Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005;28(5):1231-9
   PubMed Web of Science ®Google Scholar
• Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy: a meta-analysis. Diabetes Care 2003;26(4):1079-87
   PubMed Web of Science ®Google Scholar
• Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343(4):230-8
   PubMed Web of Science ®Google Scholar
• Orive G, Hernandez RM, Gascon AR, et al. Cell encapsulation: promise and progress. Nat Med 2003;9(1):104-7
   PubMed Web of Science ®Google Scholar
• Pagliuca FW, Melton DA. How to make a functional beta-cell. Development 2013;140(12):2472-83
   PubMed Web of Science ®Google Scholar
• Pagliuca FW, Millman JR, Gurtler M, et al. Generation of functional human pancreatic beta cells in vitro. Cell 2014;159(2):428-39
   PubMed Web of Science ®Google Scholar
• MacKenzie DA, Hullett DA, Sollinger HW. Xenogeneic transplantation of porcine islets: an overview. Transplantation 2003;76(6):887-91
   PubMed Web of Science ®Google Scholar
• O’Sullivan ES, Vegas A, Anderson DG, Weir GC. Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. Endocr Rev 2011;32(6):827-44
   PubMed Web of Science ®Google Scholar
• Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980;210(4472):908-10
   PubMed Web of Science ®Google Scholar
• Brownlee M, Cerami A. A glucose-controlled insulin-delivery system: semisynthetic insulin bound to lectin. Science 1979;206(4423):1190-1
   PubMed Web of Science ®Google Scholar
• Pai CM, Bae YH, Mack EJ, et al. Concanavalin-a microspheres for a self-regulating insulin delivery system. J Pharm Sci 1992;81(6):532-6
   PubMed Web of Science ®Google Scholar
• Makino K, Mack EJ, Okano T, Kim SW. A Microcapsule self-regulating delivery system for insulin. J Controlled Rel 1990;12(3):235-9
   Web of Science ®Google Scholar
• Seminoff LA, Olsen GB, Kim SW. A self-regulating insulin delivery system. 1. characterization of a synthetic glycosylated insulin derivative. Int J Pharmaceutics 1989;54(3):241-9
   Web of Science ®Google Scholar
• Seminoff LA, Gleeson JM, Zheng J, et al. A Self-Regulating insulin delivery system. 2. Invivo Characteristics of a synthetic glycosylated insulin. Int J Pharmaceutics 1989;54(3):251-7
   Web of Science ®Google Scholar
• Holmberg DL, Jeong SY, Kim SW, Mcrea JC. Development of a self-regulating insulin delivery system. Vet Surg 1987;16(1):92-2
   Web of Science ®Google Scholar
• Sung WK, Chaul MP, Makino K, et al. Self-regulated glycosylated insulin delivery. J Controlled Rel 1990;11(1-3):193-201
   Web of Science ®Google Scholar
• Tjota MY, Kozak BM, Chang EM, Close KL. Journal of Diabetes NEWS. J Diabetes 2011;3(2):95-102
   PubMedGoogle Scholar
• Zion TC, Zarur A, Ying JY. editors. U.S.P.a.T. Office. Stimuli-responsive systems for controlled drug delivery. Massachusetts Institute of Technology; USA: 2009
   Google Scholar
• Zion TC, Lancaster TM. editors. U.S.P.a.T. Office. Crystalline insulin-conjugates. Smartcells, Inc., USA; 2011
   Google Scholar
• Hoeg-Jensen T, Havelund S, Nielsen PK, Markussen J. Reversible insulin self-assembly under carbohydrate control. J Am Chem Soc 2005;127(17):6158-9
   PubMed Web of Science ®Google Scholar
• Hoeg-Jensen T, Ridderberg S, Havelund S, et al. Insulins with built-in glucose sensors for glucose responsive insulin release. J Pept Sci 2005;11(6):339-46
   PubMed Web of Science ®Google Scholar
• Chou DH, Webber MJ, Tang BC, et al. Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates. Proc Natl Acad Sci USA 2015;112(8):2401-6
   PubMed Web of Science ®Google Scholar
• James TD, Sandanayake KRA, Shinkai S. Saccharide sensing with molecular receptors based on boronic acid. Angew Chem Int Ed Engl 1996;35(17):1910-22
   Web of Science ®Google Scholar
• Hoeg-Jensen L, Havelund S, Oster-Gaard S, et al. editors. W.I.P. Organization. Glucose dependent release of insulin from glucose sensing insulin derivatives. Novo Nordisk A/S, Bagsvaerd, Denmark; 2001
   Google Scholar
• Hoeg-Jensen L, Jakobsen P, Sensfuss U, et al. editors. U.S.P.a.T. Office. Insulin Derivatives. Novo Nordisk A/S, Bagsvaerd, Denmark; 2012
   Google Scholar
• Kurtzhals P, Havelund S, Jonassen I, et al. Albumin binding and time action of acylated insulins in various species. J Pharm Sci 1996;85(3):304-8
   PubMed Web of Science ®Google Scholar
• Kurtzhals P, Havelund S, Jonassen I, et al. Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. Biochem J 1995;312(Pt 3):725-31
   PubMed Web of Science ®Google Scholar
• Vinik A. The question is, my dear watson, why did the dog not bark?: the joslin 50 year medalist study. Diabetes Care 2011;34(4):1060-3
   PubMed Web of Science ®Google Scholar